Feed: Slashdot
Feed Link: https://slashdot.org/
---

Title: White House Asks FDA To Review Pharma Advertising On TV

Link: https://science.slashdot.org/story/25/09/10/2...

President Trump on Tuesday issued a memorandum directing the FDA and HHS to
crack down on misleading direct-to-consumer prescription drug ads, requiring
clearer disclosure of risks and ensuring that promotions don't overstate
benefits or push costly drugs over generics. Longtime Slashdot reader sinij
shares an excerpt from the memorandum: The Secretary of Health and Human
Services shall therefore take appropriate action to ensure transparency and
accuracy in direct-to-consumer prescription drug advertising, including by
increasing the amount of information regarding any risks associated with the
use of any such prescription drug required to be provided in prescription
drug advertisements, to the extent permitted by applicable law. The
Commissioner of Food and Drugs shall take appropriate action to enforce the
Federal Food, Drug, and Cosmetic Act's prescription drug advertising
provisions, and otherwise ensure truthful and non-misleading information in
direct-to-consumer prescription drug advertisements. "Advertising dollars is
a major avenue for pharmaceutical companies to influence news and attempt to
shape public opinion," comments sinij. "Advertising was a major contributor
to painkiller addiction, where networks were hesitant to cover early reports
of addictiveness. It is likely directly contributing today to lack of
critical coverage of Ozempic. It is just too big of a conflict of interest to
allow to stand."

Read more of this story at Slashdot.

---
VRSS v2.1.180528